Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RP11-214K3.25 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
mRNA | SGMS2 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-06 |
mRNA | RALYL | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
mRNA | ZNF84 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
mRNA | ZNF420 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
mRNA | DYRK1B | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
mRNA | ATXN7L3B | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
mRNA | NEURL1B | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
mRNA | SOX11 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-06 |
mRNA | IGFBPL1 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |